Facebook picto   picto linkdink   picto tiwter


May 5, 2022
EDAP to Showcase its Focal One® Platform at the Annual Meeting of the American Urological Association (AUA)


EDAP to Showcase its Focal One® Platform at the Annual Meeting of the American Urological Association (AUA)

AUA is the largest annual gathering of urologists worldwide

EDAP TMS SA, the global leader in robotic energy-based therapies, today announced that the company will be showcasing and exhibiting itsFocal One® Robotic High Intensity Focused Ultrasound (HIFU) platform at the upcoming Annual Meeting of the American Urological Association (AUA), the largest gathering of urologists worldwide, which will be held May 13th through 15th in New Orleans.

Focal One® will be a featured topic at AUA, during both plenary presentations and instructional courses. Several notable presentations will be given by leading academic centers describing the growing clinical acceptance of the role of focal therapy in the management of prostate cancer. An AUA hands-on skills training will be teaching urologists how to implement focal treatments in their practice and will allow them to utilize Focal One® under the guidance of expert faculty.

Ryan Rhodes, CEO of EDAP U.S., said, “We are very pleased to have such a notable presence at AUA, the most high-profile urology meeting of the year. Focal therapy is quickly becoming a necessary prostate cancer treatment option, and we are pleased that many highly regarded healthcare institutions will be on hand to describe their experience to date. We believe Focal One® is the most advanced focal therapy platform available today, and we look forward to demonstrating this cutting-edge technology to the many urology thought leaders who will be in attendance.”    

Ongoing Focal One® and ExactVu™ Micro-Ultrasound hands-on simulations will be provided to urologists at the EDAP Focal One® booth (#117) throughout the meeting. ExactVu™ will be featured in two skill-enhancement workshops about the scientific evidence of microultrasound and the flexibility for transperineal or transrectal approaches.